Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Congenital Disorders of Glycosylation Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 51 | 41 |
|
Congenital Disorders of Glycolysation Asper Biogene Asper Biogene LLC Estonia | 53 | 49 |
|
Congenital disorders of glycosylation, type II: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 17 | 17 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
CEREBROCOSTOMANDIBULAR-LIKE SYNDROME Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Congenital Disorders of Glycosylation, Panel Massive Sequencing (NGS) 30 Genes Reference Laboratory Genetics Spain | 30 | 30 |
|
Congenital disorder of multiple glycosylation (CDG) GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 35 | 31 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Congenital Disorders of Glycosylation NGS Panel Fulgent Genetics United States | 43 | 39 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.